Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.89 USD | +1.71% | +7.00% | +18.29% |
05-07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
05-07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.29% | 5.49B | |
+4.50% | 109B | |
+11.43% | 105B | |
+0.70% | 22.25B | |
-11.55% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.50% | 16.85B | |
+4.43% | 13.76B | |
+36.89% | 12.46B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Sector Update: Health Care Stocks Drifting Away from Wednesday Session Highs